| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Former 10% Owner | 10% Owner
1 company
Lux Ventures IV, L.P. last filed a Form 4 in December 2021, as Former 10% Owner at RXRX.
At the last filing, the largest reported position was 13,021,519 shares of RXRX. Net of sales, the RXRX filings show accumulation of 100,000 shares.
Lux Ventures IV, L.P. has 2 Form 4 filings on record from April 2021 to December 2021, all as Former 10% Owner at Recursion Pharmaceuticals (RXRX), 2021.
The 5 reported transactions were 3 conversions, 1 other transaction and 1 open-market purchase.
Counted by filing, the open-market trades come to 1 purchase worth about $1.8M and no sales.
The only open-market purchase was 100,000 shares of RXRX at an average $18.00 on April 16, 2021, about $1.8M. Twelve months later RXRX was down 79%.
Shares as reported in the last Form 4 for each company; the most recent is from December 2021. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 16, 2021 | RXRX Recursion Pharmaceuticals, Inc. | 10% Owner | Buy | 100,000 | $18.00 | $1,800,000.00 | New | +3.8% | -79.1% |